Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

ClinicalTrials.gov ID: NCT06742996

Public ClinicalTrials.gov record NCT06742996. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 12, 2026, 5:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized Double-Blind Multicenter Study of Sonrotoclax Plus Zanubrutinib Versus Placebo Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this study is to compare how well sonrotoclax plus zanubrutinib works versus zanubrutinib plus placebo in treating adults with relapsed/refractory (R/R) mantle cell lymphoma (MCL). This study will also look at the safety of sonrotoclax plus zanubrutinib versus zanubrutinib plus placebo.

Study identification

NCT ID
NCT06742996
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
BeOne Medicines
Industry
Enrollment
300 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 4, 2025
Primary completion
Aug 30, 2028
Completion
Mar 29, 2032
Last update posted
Aug 18, 2026

2025 – 2032

United States locations

U.S. sites
41
U.S. states
26
U.S. cities
37
Facility City State ZIP Site status
University of Alabama At Birmingham Hospital Birmingham Alabama 35294-0004 Recruiting
University of Arizona Cancer Center Tucson Arizona 85724-0001 Recruiting
Ucsf Fresno Fresno California 93701 Recruiting
Kaiser Permanente Southern California Irvine California 92618-3734 Recruiting
Yale University Yale Cancer Center New Haven Connecticut 06520-8028 Recruiting
Memorial Cancer Institute, Memorial Healthcare System Pembroke Pines Florida 33026-4119 Recruiting
Cleveland Clinic Florida Weston Florida 33331-3609 Recruiting
Rush University Medical Center Chicago Illinois 60607 Recruiting
University of Chicago Medical Center Chicago Illinois 60637-1443 Recruiting
Fort Wayne Medical Oncology and Hematology Fort Wayne Indiana 46804 Recruiting
Mission Cancer and Blood Waukee Iowa 50263 Recruiting
Our Lady of the Lake Hospital Baton Rouge Louisiana 70808-4365 Recruiting
The University of Maryland Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201 Recruiting
Dana Farber Cancer Institute Longwood Medical Center Boston Massachusetts 02215-5418 Recruiting
University of Michigan Ann Arbor Michigan 48109-1382 Recruiting
The Cancer and Hematology Centers Grand Rapids Michigan 49503-2563 Recruiting
Mayo Clinic Rochester Rochester Minnesota 55905-0001 Recruiting
Hattiesburg Hematology and Oncology Clinic Hattiesburg Mississippi 39401-7233 Recruiting
Washington University School of Medicine St Louis Missouri 63110-1010 Recruiting
Nebraska Cancer Specialists St Francis Grand Island Grand Island Nebraska 68803 Recruiting
Nebraska Cancer Specialists Omaha Nebraska 68130-2042 Recruiting
The Valley Hospital, Inc Paramus New Jersey 07652 Recruiting
Memorial Sloan Kettering Cancer Center Mskcc New York New York 10065-6800 Recruiting
Atrium Health Levine Cancer Institute (Lci) Charlotte North Carolina 28204-2990 Recruiting
Duke University Durham North Carolina 27710 Recruiting
Atrium Health Wake Forest Baptist Winston-Salem North Carolina 27157 Recruiting
University Hospitals Cleveland Ohio 44106-1716 Recruiting
Cleveland Clinic Foundation Cleveland Ohio 44195-0001 Recruiting
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210-1280 Recruiting
Ohio Health Research Institute Columbus Ohio 43214-3907 Recruiting
Penn State Milton S Hershey Medical Center Hershey Pennsylvania 17033 Recruiting
McGlinn Cancer Institute West Reading Pennsylvania 19611-2143 Recruiting
Tennessee Oncology Nashville St Thomas Midtown Clinic Nashville Tennessee 37205 Recruiting
Tennessee Oncology Nashville Tennessee 37205 Recruiting
Md Anderson Cancer Center Houston Texas 77030-3907 Recruiting
Texas Oncology Austin Midtown Round Rock Texas 78681-4019 Recruiting
University of Virginia Charlottesville Virginia 22908-0817 Recruiting
Virgina Cancer Specialists Gainesville Virginia 20155-3257 Recruiting
Vcu Massey Cancer Center Richmond Virginia 23298-5026 Recruiting
Northwest Cancer Specialist, Pc(Us Oncology Research) Vancouver Washington 98684-6930 Recruiting
University of Wisconsin Madison Wisconsin 53792-0001 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 114 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06742996, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 18, 2026 · Synced Sep 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06742996 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →